Evidence map›Paper›PMID 24378850›Full record

ArticleInternational journal of molecular sciences2013

DNA repair gene XRCC4 codon 247 polymorphism modified diffusely infiltrating astrocytoma risk and prognosis.

Zhong-Hui Lin, Jin-Chun Chen, Yun-Sun Wang, Teng-Jiao Huang, Jin Wang, Xi-Dai Long

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Alkylating anticancer agents and their relations to microRNAs.Cancer drug resistance (Alhambra, Calif.) · 2019
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhong-Hui LinDepartment of Neurology Medicine, Xia-Men Hospital of Traditional Chinese Medicine, Xiamen 361009, China. forestlzh@aliyun.com.
Jin-Chun ChenDepartment of Neurology Medicine, Xia-Men Hospital of Traditional Chinese Medicine, Xiamen 361009, China. fjchenjc@163.com.
Yun-Sun WangDepartment of Neurology Medicine, Xia-Men Hospital of Traditional Chinese Medicine, Xiamen 361009, China. fjxmwangsy@163.com.
Teng-Jiao HuangDepartment of Neurology Medicine, Xia-Men Hospital of Traditional Chinese Medicine, Xiamen 361009, China. xmwangtj@163.com.
Jin WangDepartment of Neurology Medicine, Xia-Men Hospital of Traditional Chinese Medicine, Xiamen 361009, China. gxwjmc1986@163.com.
Xi-Dai LongDepartment of Neurology Medicine, Xia-Men Hospital of Traditional Chinese Medicine, Xiamen 361009, China. sjtulongxd@263.net.
Guangxi Medical University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DNA repair gene X-ray cross-complementary group 4 (XRCC4), an important caretaker of the overall genome stability, is thought to play a major role in human tumorigenesis. We investigated the association between an important polymorphic variant of this gene at codon 247 (rs373409) and diffusely infiltrating astrocytoma (DIA) risk and prognosis. This hospital-based case-control study investigated this association in the Guangxi population. In total, 242 cases with DIA and 358 age-, sex-, and race-matched healthy controls were genotyped using TaqMan-PCR technique. We found a significant difference in the frequency of XRCC4 genotypes between cases and controls. Compared with the homozygote of XRCC4 codon 247 Ala alleles (XRCC4-AA), the genotypes of XRCC4 codon 247 Ser alleles (namely XRCC4-AS or -SS) increased DIA risk (odds ratios [OR], 1.82 and 2.89, respectively). Furthermore, XRCC4 polymorphism was correlated with tumor dedifferentiation of DIA (r = 0.261, p < 0.01). Additionally, this polymorphism modified the overall survival of DIA patients (the median survival times were 26, 14, and 8 months for patients with XRCC4-AA, -AS, and -SS, respectively). Like tumor grade, XRCC4 codon 247 polymorphism was an independent prognostic factor influencing the survival of DIA. These results suggest that XRCC4 codon 247 polymorphism may be associated with DIA risk and prognosis among the Guangxi population.

Indexed as

Polymorphism, Single NucleotideAdultAgedAge FactorsAllelesAstrocytomaBrain NeoplasmsCase-Control StudiesCodonDNA-Binding ProteinsFemaleGene FrequencyGenotypeHomozygoteHumansMaleCodonDNA-Binding ProteinsXRCC4 protein, human

Identifiers

PMID24378850
PMCPMC3907808
OpenAlexW2090914721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.